LS Special Purpose Acquisition No1 Company (KOSDAQ:0041J0)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,992.00
-4.00 (-0.20%)
Last updated: Aug 7, 2025
-0.20%
Market Cap8.20B
Revenuen/a
Net Incomen/a
Shares Out4.11M
EPSn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,457
Average Volume7,951,991
Open1,995.00
Previous Close1,996.00
Day's Range1,991.00 - 1,996.00
52-Week Range1,990.00 - 5,040.00
Betan/a
RSIn/a
Earnings Daten/a

About Verve Therapeutics

LS Special Purpose Acquisition No1 Company focuses on acquiring and merging with other activities auxiliary to financial services. The company was founded in 2025 and is based in Seoul, South Korea. [Read more]

Industry Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
Founded 2025
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 0041J0
Full Company Profile

News

There is no news available yet.